24 May 2013
Keywords: roche, signs, 470m, hcv, deal, intermune, swiss
Article | 23 October 2006
Swiss drug major Roche and California, USA-based biotechnology firm InterMune have entered into an exclusive worldwide collaboration
agreement to develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2006
23 May 2013
© 2013 thepharmaletter.com